Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Finkelstein

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Biometrics|June 1, 1991
Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experimentD M Finkelstein
Biometrics|December 1, 1986
A proportional hazards model for interval-censored failure time dataD M Finkelstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Second malignancies in Hodgkin's diseaseA C Aisenberg, D M Finkelstein
The Journal of Otolaryngology|October 1, 1990
Cell surface recognition determinants involved in triggering the lymphokine activated killer cell phenomenon: enhanced killing of modified "anti-self" targets by varying LAK culture conditionsD M Finkelstein, R G Miller
Statistics in Medicine|September 15, 1994
Analysing survival in the presence of an auxiliary variableD M Finkelstein, D A Schoenfeld
Statistics in Medicine|November 2, 1999
An extension of Kendall's coefficient of concordance to bivariate interval censored dataR A Betensky, D M Finkelstein
Statistics in Medicine|July 10, 1999
Combining mortality and longitudinal measures in clinical trialsD M Finkelstein, D A Schoenfeld
The Journal of Otolaryngology|August 1, 1989
Sternocostoclavicular hyperostosis (SCCH) presenting as a mass in the neckD M Finkelstein, A M Noyek
Statistics in Medicine|November 2, 1999
A non-parametric maximum likelihood estimator for bivariate interval censored dataR A Betensky, D M Finkelstein
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacityD M Finkelstein, R G Miller
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Biometrics|June 1, 1991
Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experimentD M Finkelstein
Biometrics|December 1, 1986
A proportional hazards model for interval-censored failure time dataD M Finkelstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Second malignancies in Hodgkin's diseaseA C Aisenberg, D M Finkelstein
The Journal of Otolaryngology|October 1, 1990
Cell surface recognition determinants involved in triggering the lymphokine activated killer cell phenomenon: enhanced killing of modified "anti-self" targets by varying LAK culture conditionsD M Finkelstein, R G Miller
Statistics in Medicine|September 15, 1994
Analysing survival in the presence of an auxiliary variableD M Finkelstein, D A Schoenfeld
Statistics in Medicine|November 2, 1999
An extension of Kendall's coefficient of concordance to bivariate interval censored dataR A Betensky, D M Finkelstein
Statistics in Medicine|July 10, 1999
Combining mortality and longitudinal measures in clinical trialsD M Finkelstein, D A Schoenfeld
The Journal of Otolaryngology|August 1, 1989
Sternocostoclavicular hyperostosis (SCCH) presenting as a mass in the neckD M Finkelstein, A M Noyek
Statistics in Medicine|November 2, 1999
A non-parametric maximum likelihood estimator for bivariate interval censored dataR A Betensky, D M Finkelstein
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Effect of culture media on lymphokine-activated killer effector phenotype and lytic capacityD M Finkelstein, R G Miller
Pageof 9